Exelixis Inc (NASDAQ:EXEL)

21.57
Delayed Data
As of Jul 01
 +0.75 / +3.60%
Today’s Change
15.50
Today|||52-Week Range
23.40
+18.00%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$6.9B

Company Description

Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of COMETRIQ, CABOMETYX, COTELLIC, and MINNEBRO. The company was founded by Corey S. Goodman and Stelios B. Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.

Contact Information

Exelixis, Inc.
1851 Harbor Bay Parkway
Alameda California 94502
P:(650) 837-7000
Investor Relations:
(650) 837-8194

Employees

Shareholders

Mutual fund holders50.70%
Other institutional34.58%
Individual stakeholders3.32%

Top Executives

Michael M. MorrisseyPresident, Chief Executive Officer & Director
Dana T. AftabExecutive Vice President-Business Operations
Christopher J. SennerChief Financial Officer & Executive Vice President
Peter LambChief Scientific Officer & EVP-Scientific Strategy
Vicki L. GoodmanChief Medical Officer & Executive Vice President